Digital Companions for Patient Success

Digital companions are revolutionizing the post-prescription landscape, turning traditional patient support upside down. Cathy Zaremba, Senior Director of Marketing at Medisafe, reveals how personalized, data-driven platforms are transforming medication adherence and patient outcomes through just-in-time interventions.

The statistics are sobering: only 50% of patients with chronic conditions adhere to treatments long-term, costing the US healthcare system an estimated $300 billion annually. Meanwhile, 71% of patients crave digital experiences that align with their personal habits. Medisafe addresses this gap with sophisticated technology that meets patients exactly where they are in their therapeutic journey.

What makes digital companions effective isn't just technology—it's empathy. "Information alone doesn't change behavior," Zaremba explains. Through intelligent design and personalized support, Medisafe users stay engaged for an average of 17 months (compared to typical 30-day drop-offs), with 70% interacting at least once daily. Simple empathetic language has shown to improve engagement by over 40% during challenging therapy points, proving that patients "aren't just engaging with tech, they're engaging with trust."

The conversation explores Medisafe's exciting innovations, including Via—their voice intelligent agent combining conversational AI with behavioral data to create natural, supportive interactions. Zaremba also shares how Medisafe captures over 50 billion data points globally, providing pharma companies with unprecedented visibility into patient behavior patterns that were previously invisible through traditional reporting.

As healthcare continues evolving toward value-based care, Medisafe is expanding AI-powered predictive adherence tools and integrations across health ecosystems. The message is clear: the future of patient support isn't just about prescriptions written—it's about prescriptions completed and lives improved.

Listen now to discover how digital companions are becoming the critical difference-maker in patient success stories worldwide. Follow Postscript for more insights at the intersection of pharma, technology, and patient impact.

PostScripts Rx is not intended to constitute medical advice, nor is it intended to influence prescribing decisions or any other medical or clinical decision-making. All medical and clinical judgment and decision-making, prescribing decisions, and all related considerations remain exclusively the responsibility of providers and patients.